New Elite Feature: Chart Templates — Your indicators and design everywhere on Finviz

5 Biotech Stocks to Buy in 2025 Amid Uncertain Macroenvironment

By Ekta Bagri | July 02, 2025, 9:28 AM

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Exelixis, Inc. (EXEL): Free Stock Analysis Report

Alkermes plc (ALKS): Free Stock Analysis Report

Verona Pharma PLC American Depositary Share (VRNA): Free Stock Analysis Report

Kiniksa Pharmaceuticals International, plc (KNSA): Free Stock Analysis Report

Immunocore Holdings PLC Sponsored ADR (IMCR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Immunocore Holdings plc ADR

Kiniksa Pharmaceuticals International Plc

Latest News

Apr-06	Stock Of The Day In Buy Zone, Leads Industry Despite Supersmall Market KNSA Investor's Business Daily
Apr-06	Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference IMCR GlobeNewswire
Apr-01	Alkermes Announces Initiation of Phase 3 Brilliance Studies Evaluating Alixorexton for the Treatment of Narcolepsy Type 1 and Type 2 ALKS Business Wire
Mar-30	Lillys AI commitment expands through deal with Insilico EXEL BioPharma Dive
Mar-17	Immunocore will present five-year overall survival data for KIMMTRAK during oral presentation at the 2026 AACR meeting IMCR GlobeNewswire
Mar-16	Qualcomm, Adobe downgraded: Wall Street's top analyst calls IMCR The Fly
Mar-12	Alkermes Announces Inaugural Alkermes Pathways APN Research Awards Program ALKS Business Wire
Mar-11	New Strong Sell Stocks for March 11th ALKS Zacks
Mar-10	Alkermes to Present at the Stifel 2026 Virtual CNS Forum ALKS Business Wire
Mar-06	Biopharmas recent string of CEO splits ALKS Pharma Voice
Mar-05	Next-Generation Cancer Therapies Post Breakthrough Results Across Multiple Tumor Types IMCR -5.34% PR Newswire
Mar-04	Xenon Pharmaceuticals Stock Sees RS Rating Rise To 77 KNSA Investor's Business Daily
Mar-03	Immunocore to present at upcoming investor conferences IMCR GlobeNewswire
Mar-02	Alkermes Pivots Deeper Into Sleep Medicine After Avadel Deal, Details Orexin Phase 3 at TD Cowen ALKS MarketBeat
Mar-02	Why Exelixis (EXEL) is a Top Value Stock for the Long-Term EXEL -6.88% Zacks

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)